the post-car prognostic index (pc-pi) for predicting os in large b-cell lymphoma
Published 7 months ago • 71 plays • Length 1:48Download video MP4
Download video MP3
Similar videos
-
0:43
the development of a composite comorbidity index to predict car-t outcomes in patients with dlbcl
-
1:06
assessing metabolic tumor volume as a prognostic marker before car-t therapy for dlbcl
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
3:53
standard-of-care setting results of axi-cel in r/r large b-cell lymphoma
-
6:38
the sequencing of cd19-targeting car-ts and cd20-targeting bispecifics in dlbcl
-
2:25
the future of car-t for the treatment of lymphoma
-
1:50
outcomes of patients with dlbcl following asct and/or car-t
-
4:56
icml 2023 data-efficient contrastive self-supervised learning
-
5:03
how to read the dicom files by postdicom. #postdicom #acteon #cbct
-
6:03
what is health monitoring?
-
0:35
the importance of patient monitoring post-car-t treatment
-
2:40
the impact of car-t on the role of sct in lymphoma
-
3:31
a summary of the prognostic factors that can influence the outcomes of anti-cd19 car-t in r/r dlbcl
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
3:21
practical considerations for car-t therapy in lymphoma
-
2:30
car-t as a new standard of care in lymphoma
-
2:38
zuma-1 & scholar-1: comparison of outcomes in refractory dlbcl
-
6:14
horizon scan of car-t for lymphoma
-
1:02
the use of car-t cell products in a real-world setting
-
2:49
exploring available third-line treatment options for r/r dlbcl: car-t, bispecifics, adcs & mabs
-
1:14
initial data for car t-cell product jcar021 in all and b-cell lymphoma